COPD and Asthma Devices Market by Product Type, Distribution Channel, End User 2024-2032 - PowerPoint PPT Presentation

About This Presentation
Title:

COPD and Asthma Devices Market by Product Type, Distribution Channel, End User 2024-2032

Description:

According to the latest research report by IMARC Group, The global COPD and asthma devices market size reached US$ 45.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 69.5 Billion by 2032, exhibiting a growth rate (CAGR) of 4.6% during 2024-2032. More Info:- – PowerPoint PPT presentation

Number of Views:0
Slides: 13
Provided by: MarcelMikaelson
Category:
Tags:

less

Transcript and Presenter's Notes

Title: COPD and Asthma Devices Market by Product Type, Distribution Channel, End User 2024-2032


1
Global COPD and Asthma Devices Market Research
and Forecast Report 2024-2032
  • Format PDFEXCEL

2023 IMARC All Rights Reserved
2
About IMARC Group
  • International Market Analysis Research and
    Consulting Group is a leading adviser on
    management strategy and market research
    worldwide. We partner with clients in all regions
    and industry verticals to identify their
    highest-value opportunities, address their most
    critical challenges, and transform their
    businesses.
  • IMARCs information products include major
    market, scientific, economic and technological
    developments for business leaders in
    pharmaceutical, industrial, and high technology
    organizations. Market forecasts and industry
    analysis for biotechnology, advanced materials,
    chemicals, food and beverage, travel and tourism,
    nanotechnology and novel processing methods are
    at the top of the companys expertise.
  • IMARCs tailored approach combines unfathomable
    insight into the dynamics of companies and
    markets with close cooperation at all levels of
    the client organization. This ensures that our
    clients achieve unmatchable competitive
    advantage, build more proficient organizations,
    and secure lasting results.

3
Report Highlight and Description
  • According to the latest report by IMARC Group,
    titled "COPD and Asthma Devices Market Global
    Industry Trends, Share, Size, Growth, Opportunity
    and Forecast 2024-2032," the global COPD and
    asthma devices market size reached US 45.7
    Billion in 2023.
  • COPD and asthma devices are medical equipment
    designed to help patients manage their symptoms
    of chronic obstructive pulmonary disease (COPD)
    and asthma. They provide the user with data on
    respiratory functions, along with therapy to aid
    in controlling their symptoms. COPD devices help
    in monitoring lung function, tracking
    medications, detecting early signs of
    exacerbations, and providing reminders for
    treatments.
  • On the other hand, asthma devices provide data on
    air quality levels and monitor peak flow
    measurements and other asthma triggers. The
    demand for COPD and asthma devices is continually
    increasing as they improve the quality of life of
    the patients by providing the user with the tools
    they need to manage their condition better.
  • Request for a PDF sample of this report
    https//www.imarcgroup.com/copd-asthma-devices-mar
    ket/requestsample

4
Report Description
  • Global COPD and Asthma Devices Market Trends
  • The rising prevalence of chronic diseases among
    the masses majorly drives the global market. This
    can be supported by the growing pollution levels
    and the escalating number of cigarette smokers
    across the globe. Coupled with this, the
    increasing incidences of chronic respiratory
    diseases (CRDs), including chronic obstructive
    pulmonary disease (COPD), lung disorders,
    pulmonary hypertension (PH), bronchial asthma,
    and cystic fibrosis among individuals, are
    catalyzing the demand for COPD and asthma
    devices. Apart from this, the occupational
    exposure to dust in forestry, mining, and
    agricultural sectors is also accelerating the
    demand for effective airway management devices,
    thereby propelling the market.
  • In addition, the augmenting adoption of connected
    medical devices among healthcare professionals to
    ensure that patients receive the best care and
    consultation possible, regardless of the
    circumstance, is acting as a growth-inducing
    factor. Moreover, various leading manufacturers
    are developing more effective and efficient COPD
    and asthma devices to improve the efficiency of
    medication management, along with continuous
    developments in home-based COPD and asthma
    treatments, thus creating a positive market
    outlook. Some of the other factors driving the
    market include the rising healthcare expenditure
    and growing reimbursement schemes offered by
    health insurance companies.
  • Looking forward, the market is anticipated to
    reach a value of US 69.5 Billion by 2032,
    exhibiting a CAGR of 4.6 during 2024-2032.
  • View Report TOC, Figures and Tables
    https//www.imarcgroup.com/copd-asthma-devices-mar
    ket

5
Report Segmentation
  • Breakup by Product
  • Inhalers
  • Drug Powdered Inhalers (DPIs)
  • Metered Dose Inhalers (MDIs)
  • Soft Mist Inhalers
  • Nebulizers
  • Compressor Nebulizers
  • Ultrasonic Nebulizers
  • Mesh Nebulizers
  •  Breakup by Indication
  • Asthma
  • COPD
  • Breakup by Distribution Channel
  • Retail Pharmacies

6
Report Segmentation
  • Hospitals
  • Online Pharmacies
  • Breakup by Region
  • North America
  • Asia-Pacific
  • Europe
  • Latin America
  • Middle East and Africa

7
Competitive Landscape with Key Players
  • Adherium Limited
  • Aristopharma Ltd.
  • AstraZeneca PLC
  • Baxter International Inc.
  • Boehringer Ingelheim International GmbH
  • Cohero Health Inc.
  • Koninklijke Philips N.V.
  • Omron Corporation
  • Pari Respiratory Equipment Inc.
  • Recipharm AB
  • Verona Pharma plc.

8
Key Questions Answered in the Report
9
Table of Contents
  • 1    Preface2    Scope and Methodology    2.1  
     Objectives of the Study    2.2  
     Stakeholders    2.3    Data Sources       
    2.3.1    Primary Sources        2.3.2  
     Secondary Sources    2.4    Market Estimation 
          2.4.1    Bottom-Up Approach        2.4.2  
     Top-Down Approach    2.5    Forecasting
    Methodology3    Executive Summary4  
     Introduction    4.1    Overview    4.2    Key
    Industry Trends5    Global COPD and Asthma
    Devices Market    5.1    Market Overview    5.2
       Market Performance    5.3    Impact of
    COVID-19  5.4    Market Forecast
  • 6     Market Breakup by Product    6.1  
     Inhalers        6.1.1 Market Trends       
    6.1.2 Key Segments           6.1.2.1 Drug
    Powdered Inhalers (DPIs)           6.1.2.2
    Metered Dose Inhalers (MDIs)           6.1.2.3
    Soft Mist Inhalers        6.1.3 Market
    Forecast    6.2    Nebulizers        6.2.1
    Market Trends        6.2.2 Key Segments       

10
Table of Contents
  •            6.2.2.1 Compressor Nebulizers       
       6.2.2.2 Ultrasonic Nebulizers         
     6.2.2.3 Mesh Nebulizers        6.2.3 Market
    Forecast7   Market Breakup by Indication    7.1
       Asthma        7.1.1 Market Trends       
    7.1.2 Market Forecast    7.2    COPD       
    7.2.1 Market Trends        7.2.2 Market
    Forecast8   Market Breakup by Distribution
    Channel    8.1    Retail Pharmacies       
    8.1.1 Market Trends        8.1.2 Market
    Forecast    8.2    Hospitals        8.2.1
    Market Trends        8.2.2 Market Forecast   
    8.3    Online Pharmacies        8.3.1 Market
    Trends        8.3.2 Market Forecast9   Market
    Breakup by Region    9.1    North America     
      9.1.1 United States           9.1.1.1 Market
    Trends           9.1.1.2 Market Forecast       
    9.1.2 Canada           9.1.2.1 Market Trends   
           9.1.2.2 Market Forecast    9.2  
     Asia-Pacific
  • For more information, visit https//www.imarcgrou
    p.com/copd-asthma-devices-market/toc

11
Disclaimer
  • 2023 IMARC All Rights Reserved
  • This Publication and all its contents unless
    otherwise mentioned are copyrighted in the name
    of International Market Analysis Research and
    Consulting (IMARC). No part of this publication
    may be reproduced, repackaged, redistributed or
    resold in whole or in any part. The publication
    may also not be used in any form or by and means
    graphic electronic or mechanical, including
    photocopying, recording, taping or by information
    storage or retrieval, or by any other form,
    without the express consent of International
    Market Analysis Research and Consulting (IMARC).
  • Disclaimer All contents and data of this
    publication, including forecasts, data analysis
    and opinion have been based on information and
    sources believed to be accurate and reliable at
    the time of publishing. International Market
    Analysis Research and Consulting makes no
    representation of warranty of any kind as to the
    accuracy or completeness of any Information
    provided. IMARC accepts no liability whatsoever
    for any loss or damage resulting from opinion,
    errors or inaccuracies if any found this
    publication.
  • IMARC, IMARC Group and Global Therapy Insight
    Series are registered trademarks of International
    Market Analysis Research and Consulting. All
    other trademarks used in this publication are
    registered trademarks of their respective
    companies.

12
Contact Us
Visit us at
https//www.imarcgroup.com
TELEPHONE 1-631-791-1145 E-MAIL
sales_at_imarcgroup.com
Write a Comment
User Comments (0)
About PowerShow.com